Phase 1/2 Study of Pemetrexed Plus Cisplatin in Unresectable, Advanced Gastric Carcinoma.

Trial Profile

Phase 1/2 Study of Pemetrexed Plus Cisplatin in Unresectable, Advanced Gastric Carcinoma.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 29 Sep 2009

At a glance

  • Drugs Cisplatin; Pemetrexed
  • Indications Gastric cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 24 Jul 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
    • 13 Aug 2007 Status changed from recruiting to in progress.
    • 05 May 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top